Jim Simons Acer Therapeutics Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.75 - $1.14 $6,936 - $10,542	-9,248 Reduced 8.27%	102,552 $95,000
Q1 2023 May 12, 2023	BUY	$0.67 - $3.05 $35,711 - $162,565	53,300 Added 91.11%	111,800 $85,000
Q4 2022 Feb 13, 2023	SELL	$1.13 - $4.15 $10,282 - $37,765	-9,100 Reduced 13.46%	58,500 $147,000
Q3 2022 Nov 14, 2022	SELL	$1.28 - $1.6 $2,688 - $3,360	-2,100 Reduced 3.01%	67,600 $94,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $3.04 $56,763 - $145,008	47,700 Added 216.82%	69,700 $88,000
Q1 2022 May 13, 2022	BUY	$1.98 - $2.98 $9,108 - $13,708	4,600 Added 26.44%	22,000 $64,000
Q4 2021 Feb 11, 2022	BUY	$1.88 - $2.9 $32,711 - $50,460	17,400 New	17,400 $40,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.